Bioactive Materials
Wantai BioPharm specializes in developing and producing high-quality bioactive materials and innovative diagnostic products. Leveraging our advanced technological platform, we maintain strict control over critical performance parameters including sensitivity, specificity, stability, and batch consistency. This ensures reliable product quality and supply, perfectly meeting the needs of global IVD manufacturers.
Technical Platform
Latex turbidimetric reagent development platform, chemiluminescence test development platform, coagulation test development platform, antigen expression platform, antibody screening platform, enzyme platform, and quality control material platform.
Quality Assurance
Strict Quality Control
Full-process quality control, including internal quality assessment, national panels, reference standards, and enterprise calibrators, etc.
Process Optimization
Continuously optimize the production process, develop key bioactive material processes, optimize product capacity, and improve product quality.
Standardized Production
Passed the ISO 13485 system certification, and complies with the production management system required by IVD.
For more information :  wtexport@ystwt.com